Tucatinib (Tukysa®) Management
About this PQI
The purpose of this PQI is to highlight tucatinib and its usage and management in advanced unresectable or metastatic HER2-positive breast cancer who have received one or more prior anti-HER2-based regimens in the metastatic setting.
More About This PQI
PQI:
PQI in Action Articles:
How to Use a Positive Quality Intervention (PQI)
Essentially, it’s a tool to improve patient care by sharing best practices in oncology care. Consider this standardized, peer-review clinical guidance to oncology healthcare teams, enabling you and your team to consistently deliver high-quality care to your patients.
Find a PQIFind Similar Resources
All Resources
PQI
PQI
PQI
PQI
PQI: Ibrutinib Dosing Optimization
Author: Nick Bouchard, PharmD | Danielle Maciorowski, PharmD
Last Updated: 04/19/2025
PQI: Zanubrutinib (Brukinsa®) Patient Selection and Management
Author: Kayla Randle, PharmD, BCOP
Last Updated: 04/19/2025
PQI: Zanubrutinib (Brukinsa ®) treatment for Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Author: Kirollos Hanna, PharmD, BCPS, BCOP, FACCC, FAPO
Last Updated: 04/19/2025
PQI: Vorasidenib (Voranigo®)
Author: Andrea Gómez, PharmD, BCACP
Last Updated: 04/19/2025
PQI in Action
PQI in Action
PQI in Action
PQI in Action
PQI in Action: Tremelimumab-actl (Imjudo®) Patient Management
Author: Scripps Health, CA | UPMC, PA
Last Updated: 04/19/2025
PQI in Action: Tepotinib (Tepmetko®) for Non-Small Cell Lung Cancerwith MET Exon 14 Alterations
Author: Florida Cancer Specialists & Research Institute, FL | Mayo Clinic, MN | Texas Oncology, TX
Last Updated: 04/19/2025
PQI in Action: Siltuximab (Sylvant®) in Patients with Idiopathic Multicentric Castleman Disease
Author: University of Michigan Health-Sparrow Herbert-Herman Cancer Center, MI | Texas Oncology, TX | University of North Carolina (UNC) Health, NC
Last Updated: 04/19/2025
PQI in Action: Isatuximab-irfc (Sarclisa®) in 1q21 Gain or Amplifications in Relapsed/Refractory Multiple Myeloma
Author: Texas Oncology, TX | Florida Cancer Specialists & Research Institute, FL | University Hospitals Cleveland Medical Center, OH
Last Updated: 04/19/2025
PQI Podcast
PQI Podcast
PQI Podcast
PQI Podcast
The PQI Podcast S8 Ep 10: Operationalizing Bispecifics in the Community Setting
Author: Ginger Blackmon, PharmD | Nick Bouchard, PharmD
Last Updated: 04/19/2025
The PQI Podcast S3 Ep 11: Moffitt Clinical Pharmacy Program
Author: Ginger Blackmon, PharmD | Salvatore Bottiglieri, PharmD, BCOP
Last Updated: 04/19/2025
The PQI Podcast S3 Ep 12: Health Disparities in Cancer Screenings
Author: Ginger Blackmon, PharmD | Shana O. Ntiri, MD, MPH, FAAFP,
Last Updated: 04/19/2025
The PQI Podcast S3 Ep 13: The Importance of the Multidisciplinary Team
Author: Ginger Blackmon, PharmD | April Hallatt, BSN, RN, OCN
Last Updated: 04/19/2025
Treatment Support Kit
Treatment Support Kit
Treatment Support Kit
Treatment Support Kit
Treatment Support Kit: Abemaciclib
Last Updated: 04/19/2025
Treatment Support Kit: Temozolomide
Last Updated: 04/19/2025
Treatment Support Kit: Tivozanib
Last Updated: 04/19/2025
Treatment Support Kit: Regorafenib
Last Updated: 04/19/2025
Video
Video
Video
Video
Video: Akynzeo® (Ready-to-Use Vial): A Step-by-Step Video Guide
Last Updated: 04/19/2025
Video: BRUKINSA® (Zanubrutinib) for Treatment of Relapsed or Refractory Marginal Zone Lymphoma
Author: Brad Kahl, MD
Last Updated: 04/19/2025
Video: Ibrutinib-Related Cardiac Toxicities: Management & Dose Modifications
Author: Jo Ellen Rodgers, PharmD, BCPS, BCCP
Last Updated: 04/19/2025
Video: Neratinib for Extended Adjuvent Treatment of Adult Patients with Early-Stage HER2-Positive Breast Cancer (MIP)
Author: Joyce O’Shaughnessy, MD
Last Updated: 04/19/2025
PQI
PQI
PQI
PQI
PQI: The Role of Pharmacy in Equitable Breast Cancer Care
Author: Kayla Boyd, PharmD, BCOP | Daisy Doan, PharmD
Last Updated: 04/19/2025
PQI: Stomatitis Prophylaxis During Everolimus (Afinitor®) Therapy
Author: Matthew Schulz, PharmD
Last Updated: 04/19/2025
PQI: Sacituzumab govitecan (Trodelvy®): Management of Neutropenia and Diarrhea
Author: Rebecca Martin, PharmD, BCOP
Last Updated: 04/19/2025
PQI: Overview of Breast Cancer Survivorship
Author: Tahsin Imam, PharmD
Last Updated: 04/19/2025
PQI
PQI in Action
Video
PQI in Action
PQI: Tucatinib (TUKYSA®) and trastuzumab in HER2-positive Metastatic Colorectal Cancer
Author: Matthew Arango, PharmD, BCOP
Last Updated: 04/19/2025
PQI in Action: Tucatinib (Tukysa®) and Trastuzumab in HER2-Positive Metastatic Colorectal Cancer
Author: Medstar Georgetown University Hospital Otto J. Ruesch Center for the Cure of GI Cancers, D.C. | University Hospitals Seidman Cancer Center, OH
Last Updated: 04/19/2025
Tukysa® (tucatinib) Educational Videos
Last Updated: 04/19/2025
PQI in Action: Tucatinib (Tukysa®) Management – 3
Author: Mays Cancer Center, TX | Cancer Care Specialists of Illinois, IL
Last Updated: 04/19/2025
PQI
Video
PQI in Action
PQI in Action
PQI: Tucatinib (TUKYSA®) and trastuzumab in HER2-positive Metastatic Colorectal Cancer
Author: Matthew Arango, PharmD, BCOP
Last Updated: 04/19/2025
Tukysa® (tucatinib) Educational Videos
Last Updated: 04/19/2025
PQI in Action: Tucatinib (Tukysa®) Management – 3
Author: Mays Cancer Center, TX | Cancer Care Specialists of Illinois, IL
Last Updated: 04/19/2025
PQI in Action: Tucatinib (Tukysa®) Management – 2
Author: Johns Hopkins Kimmel Cancer Center at Sibley Memorial Hospital, DC | Miami Cancer Institute, FL
Last Updated: 04/19/2025
PQI in Action
PQI Podcast
PQI Podcast
PQI Podcast
PQI in Action: Tremelimumab-actl (Imjudo®) Patient Management
Author: Scripps Health, CA | UPMC, PA
Last Updated: 04/19/2025
The PQI Podcast S8 Ep 10: Operationalizing Bispecifics in the Community Setting
Author: Ginger Blackmon, PharmD | Nick Bouchard, PharmD
Last Updated: 04/19/2025
The PQI Podcast S3 Ep 11: Moffitt Clinical Pharmacy Program
Author: Ginger Blackmon, PharmD | Salvatore Bottiglieri, PharmD, BCOP
Last Updated: 04/19/2025
The PQI Podcast S3 Ep 12: Health Disparities in Cancer Screenings
Author: Ginger Blackmon, PharmD | Shana O. Ntiri, MD, MPH, FAAFP,
Last Updated: 04/19/2025
Related Content
PQI
PQI: Tucatinib (TUKYSA®) and trastuzumab in HER2-positive Metastatic Colorectal Cancer
Last Updated: January 8, 2024